Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18892119 | SYSTEMS AND METHODS FOR ENHANCED EXTENDED CARE MANAGEMENT WITH SOCIAL DETERMINANTS OF HEALTH | September 2024 | January 2026 | Abandon | 16 | 2 | 0 | Yes | No |
| 18770292 | MEDICAL ASSISTANT | July 2024 | September 2024 | Allow | 2 | 0 | 0 | Yes | No |
| 18761890 | PREDICTING NEWLY INCIDENT CHRONIC KIDNEY DISEASE | July 2024 | August 2025 | Allow | 13 | 1 | 0 | Yes | No |
| 18671396 | SYSTEM AND METHOD FOR INDIVIDUALIZED HEALTHCARE RECOMMENDATIONS | May 2024 | August 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18653395 | AI-ASSISTED TREATMENT OPTIMIZATION LEVERAGING TREATMENT FIDELITY DATA | May 2024 | March 2025 | Allow | 11 | 1 | 0 | Yes | No |
| 18437140 | Artificial intelligence-based cognitive-coping therapy (CCT) method, system, and application | February 2024 | January 2026 | Abandon | 23 | 1 | 0 | No | No |
| 18404807 | COMPUTER VISION MICRO-SERVICE SEIZURE PREVENTION SYSTEM | January 2024 | December 2025 | Allow | 23 | 1 | 0 | Yes | No |
| 18503126 | SYSTEMS, DEVICES, AND METHODS FOR DIAGNOSTIC AID KIT APPARATUS | November 2023 | April 2025 | Abandon | 18 | 1 | 0 | Yes | No |
| 18491618 | AUTOMATED ELECTRONIC MEDICAL RECORD (EMR) ANALYSIS VIA POINT OF CARE COMPUTING SYSTEMS | October 2023 | August 2025 | Allow | 22 | 1 | 0 | Yes | No |
| 18556301 | SYSTEM, METHOD, AND APPARATUS FOR PET CONDITION DETECTION | October 2023 | January 2026 | Allow | 27 | 3 | 0 | Yes | No |
| 18489252 | APPARATUS AND METHODS FOR TRACKING PHARMACEUTICAL SAMPLES | October 2023 | March 2026 | Abandon | 29 | 1 | 0 | No | No |
| 18459794 | CHAOTIC STORAGE OF PRESCRIPTION MEDICATIONS | September 2023 | March 2025 | Abandon | 19 | 1 | 0 | No | No |
| 18239082 | SYSTEMS AND METHODS FOR DISPENSING MEDICATIONS BASED ON PROXIMITY TO AN ELECTRONIC MEDICATION STORAGE CABINET | August 2023 | October 2025 | Allow | 25 | 1 | 0 | Yes | No |
| 18335160 | Multi-agent automatic voting system for fast, on-the-fly imaging and diagnosis of retina diseases using case based expert systems | June 2023 | February 2026 | Abandon | 32 | 1 | 0 | No | No |
| 18332634 | Systems and Methods for Facilitating and Evaluating Psychological Shifts in Users | June 2023 | March 2026 | Abandon | 33 | 2 | 0 | No | No |
| 18196403 | HEALTH INFORMATION EXCHANGE SYSTEM | May 2023 | September 2025 | Abandon | 28 | 1 | 0 | No | No |
| 18300960 | System, Method, and Computer Program Product for Validating Prescriptions | April 2023 | October 2025 | Abandon | 30 | 2 | 0 | Yes | No |
| 18170582 | SYSTEMS AND METHODS FOR PROVIDING ELECTRONIC AND NON-ELECTRONIC RECORDS | February 2023 | July 2025 | Abandon | 29 | 1 | 0 | No | No |
| 18007111 | ANTIMICROBIAL CHOICE ALGORITHM FOR URINARY TRACT INFECTIONS | January 2023 | November 2025 | Abandon | 34 | 2 | 0 | No | No |
| 18101035 | EQUIPMENT UTILIZATION AND HEALTHCARE TECHNOLOGY MANAGEMENT PLATFORM | January 2023 | May 2025 | Abandon | 28 | 1 | 0 | Yes | No |
| 18156509 | METHOD AND APPARATUS FOR PROVIDING CLOUD-BASED MEDICAL COLLABORATION SERVICE FOR MEDICAL IMAGES | January 2023 | November 2025 | Abandon | 34 | 1 | 0 | No | No |
| 18066417 | SYSTEM FOR TRIGGERING PATIENT ANALYTIC SERVICES FOR A MEDICAL PROVIDER | December 2022 | October 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 18073407 | MANAGEMENT OF PSYCHIATRIC OR MENTAL CONDITIONS USING DIGITAL OR AUGMENTED REALITY WITH PERSONALIZED EXPOSURE PROGRESSION | December 2022 | July 2024 | Allow | 19 | 3 | 0 | Yes | No |
| 17933844 | ELECTRONIC SYSTEM FOR WOUND IMAGE ANALYSIS AND COMMUNICATION | September 2022 | April 2025 | Abandon | 31 | 1 | 0 | No | No |
| 17908340 | SYSTEMS AND METHODS FOR INCREASING A SLEEPINESS OF INDIVIDUALS | August 2022 | February 2026 | Allow | 42 | 4 | 1 | Yes | No |
| 17822142 | INTELLIGENT MEDICAL RESOURCE SHARING PLATFORM | August 2022 | June 2025 | Abandon | 34 | 2 | 0 | No | No |
| 17874707 | Handsfree Communication System and Method | July 2022 | January 2026 | Allow | 42 | 3 | 0 | No | No |
| 17732332 | DIRECT DATA CONNECTION FOR UNIVERSAL COLLECTION OF HEALTH DATA | April 2022 | August 2025 | Abandon | 39 | 2 | 0 | Yes | No |
| 17708790 | Cognitive behavioral therapy (CBT) method, system and application for managing tinnitus | March 2022 | June 2025 | Abandon | 38 | 2 | 0 | Yes | No |
| 17697593 | Automated Clinical Documentation System and Method | March 2022 | February 2025 | Abandon | 35 | 2 | 0 | No | No |
| 17592847 | PATIENT-CENTERED MUSCULOSKELETAL (MSK) CARE SYSTEM AND ASSOCIATED PROGRAMS FOR THERAPIES FOR DIFFERENT ANATOMICAL REGIONS | February 2022 | September 2025 | Allow | 44 | 3 | 1 | Yes | No |
| 17597916 | Consultation Assistant For Aesthetic Medical Procedures | January 2022 | November 2024 | Abandon | 34 | 1 | 0 | No | No |
| 17581339 | SYSTEM AND METHOD TO PREDICT REPRODUCIBILITY OF CLINICAL BENEFITS OF A NEW DRUG | January 2022 | December 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17580566 | HEADSET INTEGRATED INTO HEALTHCARE PLATFORM | January 2022 | June 2025 | Allow | 41 | 6 | 0 | Yes | No |
| 17646387 | MEDICAL INFORMATION PROCESSING APPARATUS | December 2021 | October 2025 | Abandon | 45 | 4 | 0 | No | No |
| 17615860 | SYSTEMS AND METHODS FOR HOSPITAL ASSET LOGISTICS OPTIMIZATION | December 2021 | July 2025 | Abandon | 43 | 3 | 0 | No | No |
| 17514165 | METHOD AND SYSTEM TO DETERMINE, TRACK, AND MITIGATE SPECIFIC PHOBIA STIMULATION FOR A PATIENT WITHIN HEALTHCARE SETUP | October 2021 | November 2025 | Abandon | 48 | 4 | 0 | Yes | No |
| 17441496 | SYSTEM, METHOD AND SOFTWARE PROGRAM FOR MANAGING THE INTERACTION BETWEEN DRUGS | September 2021 | May 2025 | Abandon | 44 | 2 | 0 | Yes | No |
| 17441037 | METHOD OF PREDICTING WHETHER A KIDNEY TRANSPLANT RECIPIENT IS AT RISK OF HAVING ALLOGRAFT LOSS | September 2021 | March 2025 | Abandon | 42 | 3 | 0 | Yes | No |
| 17436840 | ADAPTIVE CLINICAL TRIALS | September 2021 | April 2025 | Abandon | 43 | 3 | 0 | Yes | No |
| 17357124 | ELECTROCARDIOGRAM ANALYSIS MATCHING SUPPORT SERVICE SYSTEM | June 2021 | September 2025 | Abandon | 51 | 4 | 0 | Yes | No |
| 17356796 | CONTACT TRACING UTILIZING DEVICE SIGNATURES CAPTURED DURING TRANSACTIONS | June 2021 | January 2025 | Allow | 43 | 4 | 0 | Yes | No |
| 17417070 | METHOD FOR OPTIMIZATION OF CANNABIS DOSAGE AND MIXTURE OF ACTIVE CANNABINOIDS | June 2021 | October 2024 | Abandon | 39 | 1 | 1 | No | No |
| 17299433 | HEALTH MANAGEMENT SYSTEM | June 2021 | July 2025 | Abandon | 49 | 3 | 0 | No | No |
| 17308829 | SYSTEM AND METHOD FOR INDIVIDUALIZED HEALTHCARE RECOMMENDATIONS | May 2021 | November 2024 | Abandon | 42 | 2 | 0 | Yes | No |
| 17215545 | SLEEP APNEA TEST DEVICE | March 2021 | April 2025 | Allow | 49 | 3 | 1 | Yes | No |
| 17169392 | SYSTEMS AND METHODS FOR DETECTING AND TRACKING INFECTIOUS DISEASES USING SENSOR DATA | February 2021 | August 2024 | Allow | 42 | 3 | 1 | Yes | No |
| 17147593 | SYSTEM AND METHOD FOR PROCESSING MEDICAL CLAIMS USING BIOMETRIC SIGNATURES | January 2021 | November 2025 | Allow | 58 | 3 | 0 | Yes | No |
| 17128251 | DE-ESCALATING SITUATIONS | December 2020 | January 2025 | Abandon | 49 | 6 | 0 | Yes | No |
| 17105825 | Enhanced Enterprise Image Reading with Search and Direct Streaming | November 2020 | February 2025 | Allow | 50 | 4 | 0 | Yes | No |
| 17045484 | INFORMATION PROCESSING DEVICE AND INFORMATION PROCESSING METHOD | October 2020 | March 2025 | Abandon | 53 | 6 | 0 | No | No |
| 16961399 | METHODS FOR IMPROVING PSYCHOLOGICAL THERAPY OUTCOME | July 2020 | November 2024 | Abandon | 52 | 5 | 1 | Yes | No |
| 16896889 | PROVIDER-CURATED APPLICATIONS FOR ACCESSING PATIENT DATA IN AN EHR SYSTEM | June 2020 | May 2025 | Abandon | 59 | 4 | 0 | Yes | No |
| 16819133 | INTELLIGENT HEALTH PROVIDER MONITORING WITH DE-IDENTIFICATION | March 2020 | September 2022 | Abandon | 30 | 4 | 0 | No | No |
| 16340543 | DEVICE, SYSTEM, AND METHOD FOR OPTIMIZING USAGE OF PRIOR STUDIES | April 2019 | December 2025 | Abandon | 60 | 8 | 0 | No | Yes |
| 15867810 | AUTOMATED FAMILY ALERT SYSTEM | January 2018 | April 2021 | Abandon | 39 | 6 | 0 | Yes | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ALDERSON, ANNE-MARIE K.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner ALDERSON, ANNE-MARIE K works in Art Unit 3682 and has examined 22 patent applications in our dataset. With an allowance rate of 22.7%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 48 months.
Examiner ALDERSON, ANNE-MARIE K's allowance rate of 22.7% places them in the 3% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by ALDERSON, ANNE-MARIE K receive 3.86 office actions before reaching final disposition. This places the examiner in the 97% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by ALDERSON, ANNE-MARIE K is 48 months. This places the examiner in the 8% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +33.3% benefit to allowance rate for applications examined by ALDERSON, ANNE-MARIE K. This interview benefit is in the 81% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 9.3% of applications are subsequently allowed. This success rate is in the 4% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 3% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
This examiner withdraws rejections or reopens prosecution in 0.0% of appeals filed. This is in the 2% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 120.0% are granted (fully or in part). This grant rate is in the 95% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.